Published in Oncoscience on December 26, 2014
MicroRNA expression and its implications for diagnosis and therapy of gallbladder cancer. Oncotarget (2015) 1.03
The role of microRNAs expression in laryngeal cancer. Oncotarget (2015) 0.95
Inhibitory effect of miR-184 on the potential of proliferation and invasion in human glioma and breast cancer cells in vitro. Int J Clin Exp Pathol (2015) 0.79
Fragile X mental retardation protein promotes astrocytoma proliferation via the MEK/ERK signaling pathway. Oncotarget (2016) 0.75
Evaluation of rat C6 malignant glioma using spectral computed tomography. Exp Ther Med (2017) 0.75
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics (2009) 67.17
Prediction of mammalian microRNA targets. Cell (2003) 53.70
Combinatorial microRNA target predictions. Nat Genet (2005) 50.48
The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (2007) 49.11
Comprehensive molecular portraits of human breast tumours. Nature (2012) 47.39
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell (2010) 39.09
Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell (2010) 16.12
A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell (2006) 14.70
The somatic genomic landscape of glioblastoma. Cell (2013) 11.73
Genetic pathways to primary and secondary glioblastoma. Am J Pathol (2007) 9.27
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res (2008) 7.53
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science (2014) 6.09
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci U S A (2013) 5.68
An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci (2014) 5.52
Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell (2011) 4.78
Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma. Cancer Cell (2014) 2.14
A developmental taxonomy of glioblastoma defined and maintained by MicroRNAs. Cancer Res (2011) 1.89
A ten-microRNA expression signature predicts survival in glioblastoma. PLoS One (2011) 1.87
Glioblastoma models reveal the connection between adult glial progenitors and the proneural phenotype. PLoS One (2011) 1.77
Ago2 immunoprecipitation identifies predicted microRNAs in human embryonic stem cells and neural precursors. PLoS One (2009) 1.70
Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice. Neuro Oncol (2012) 1.68
Asymmetry-defective oligodendrocyte progenitors are glioma precursors. Cancer Cell (2011) 1.67
miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ. Oncogene (2011) 1.62
Epigenetic regulation of miRNA-211 by MMP-9 governs glioma cell apoptosis, chemosensitivity and radiosensitivity. Oncotarget (2012) 1.40
microRNA-451: A conditional switch controlling glioma cell proliferation and migration. Cell Cycle (2010) 1.40
Molecular diagnostics of gliomas: state of the art. Acta Neuropathol (2010) 1.40
Whole-genome microRNA expression profiling identifies a 5-microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme. Cancer (2012) 1.33
Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy. Cell Death Differ (2014) 1.32
CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells. EMBO J (2011) 1.32
miR-195, miR-455-3p and miR-10a( *) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells. Cancer Lett (2010) 1.32
Brain tumor stem cells: the cancer stem cell hypothesis writ large. Mol Oncol (2010) 1.30
MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients. Cancer Sci (2011) 1.28
MicroRNA expression profiling of oligodendrocyte differentiation from human embryonic stem cells. PLoS One (2010) 1.24
General principals of miRNA biogenesis and regulation in the brain. Neuropsychopharmacology (2012) 1.23
Enhanced stability of microRNA expression facilitates classification of FFPE tumour samples exhibiting near total mRNA degradation. Br J Cancer (2012) 1.19
The genetic landscape of anaplastic astrocytoma. Oncotarget (2014) 1.09
microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma. Cancer Res (2014) 1.07
MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications. Genome Med (2013) 1.05
The role of microRNAs in human neural stem cells, neuronal differentiation and subtype specification. Cell Tissue Res (2014) 0.98
Involvement of miRNAs in the differentiation of human glioblastoma multiforme stem-like cells. PLoS One (2013) 0.98
Inability of human induced pluripotent stem cell-hematopoietic derivatives to downregulate microRNAs in vivo reveals a block in xenograft hematopoietic regeneration. Stem Cells (2012) 0.96
Concise review: MicroRNAs as modulators of stem cells and angiogenesis. Stem Cells (2014) 0.95
MicroRNAs in cancer: glioblastoma and glioblastoma cancer stem cells. Neurochem Int (2014) 0.93
Incidence and relative survival of anaplastic astrocytomas. Neuro Oncol (2014) 0.93
Oligodendrocyte progenitor cells promote neovascularization in glioma by disrupting the blood-brain barrier. Cancer Res (2013) 0.91
Glioma development: where did it all go wrong? Cell (2011) 0.88
Intercellular cooperation and competition in brain cancers: lessons from Drosophila and human studies. Stem Cells Transl Med (2014) 0.86
Concise review: breast cancer stem cells: regulatory networks, stem cell niches, and disease relevance. Stem Cells Transl Med (2014) 0.83
Chemoresistance in high-grade gliomas: relevance of adenosine signalling in stem-like cells of glioblastoma multiforme. Curr Drug Targets (2014) 0.80
The role of microRNAs in the pancreatic differentiation of pluripotent stem cells. Microrna (2014) 0.79
Id2 mediates oligodendrocyte precursor cell maturation arrest and is tumorigenic in a PDGF-rich microenvironment. Cancer Res (2014) 0.78